Full-Time
Posted on 10/31/2025
FDA-cleared software for radiation therapy planning
$210k - $250k/yr
Remote in USA
Remote
Radformation provides FDA-cleared software tools for radiation therapy treatment planning to help clinics improve quality and efficiency. Its product suite includes ClearCheck for automated plan checks and documentation, ClearCalc for independent dose validation, EZFluence for generating 3D treatment plans, AutoContour an AI-driven contouring tool, ChartCheck for real-time patient data monitoring, and QuickCode for billing QA. These tools integrate into existing clinical workflows and are offered via software licenses with support services. Compared to competitors, Radformation offers a cohesive, FDA-cleared, multi-tool platform that covers plan checks, dose validation, plan generation, AI-assisted contouring, data monitoring, and billing QA in one ecosystem. The company’s goal is to streamline the entire treatment planning process, helping radiation oncology departments save time and resources while ensuring accurate, high-quality patient care.
Company Size
51-200
Company Stage
Early VC
Total Funding
$9.2M
Headquarters
New York City, New York
Founded
2016
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Unlimited Paid Time Off
Parental Leave
Remote Work Options
Icon Group has deployed ChartCheck Adaptive, Radformation's offline adaptive assessment solution, across 15 cancer centres in Australia. The rollout began in November and will expand to all Icon Cancer Centre locations globally in the coming months. The technology provides automated, quantitative insight into daily treatment delivery, particularly benefiting head and neck cancer cases. Early results show several patients were successfully re-planned due to anatomical changes during treatment, supporting clinical decision-making whilst maintaining efficient workflows. Radformation has secured expanded US FDA 510(k) clearance for ChartCheck to support the new adaptive functionality. The software evaluates daily imaging and treatment data to assess how dose and anatomy change throughout treatment. Icon Group, serving over 55 cancer centres globally, has partnered with Radformation as an early adopter and Centre of Excellence member.
Radformation is thrilled to announce the upcoming release of AutoContour v2.6, packed with exciting features, enhancements, and additional structure models.
Radformation, Inc. has acquired Limbus AI. This merger combines their strengths to advance AI-driven solutions, aiming to enhance patient care.
Radformation, a leader in cancer care automation, has acquired Limbus AI, a top provider of automated contouring software for radiation therapy. This merger enhances Radformation's AI capabilities and aims to integrate the best features of both companies' technologies, promising advancements in radiation therapy. The combined entity will now serve over 2,000 clinics globally, impacting 500,000 patients. This strategic move is set to drive innovation and improve patient outcomes in healthcare technology.
NOVA YORK--(BUSINESS WIRE)--Radformation, líder em soluções de software clínico e operacional para tratamento do câncer, anunciou hoje que recebeu autorizações regulatórias para suas soluções de automação de radioterapia* da Therapeutic Goods Administration (TGA) na Austrália, da Agência Nacional de Vigilância Sanitária (ANVISA) no Brasil, da Health Canada no Canadá e da Administração de Alimentos e Medicamentos (FDA) na Tailândia. “Essas autorizações refletem nosso compromisso com a inovação global em saúde e nossa dedicação em atender aos rigorosos padrões regulatórios essenciais para melhorar o atendimento aos pacientes no mundo inteiro”, disse Kurt Sysock, CEO da Radformation. Incluído nessas autorizações está o AutoContour, a solução de segmentação e perfilamento automática baseada em IA da Radformation, projetado para iniciar o processo de planejamento do tratamento. Em um estudo de caso recente, o AutoContour demonstrou diminuir o tempo de planejamento do perfilamento em uma média de 84% em todos os locais anatômicos, gerando perfilamentos altamente precisos, levando a uma melhor consistência do plano de tratamento. Os primeiros usuários brasileiros do AutoContour e do ClearCheck, o software automatizado de verificação de plano secundário da Radformation, a Liga Catarinense de Combate ao Câncer - Radioterapia São Sebastião e o Real Hospital Português de Beneficência, selecionaram as ferramentas da Radformation para complementar suas crescentes modalidades de tratamento de última geração e expandir a carga de pacientes